Telix Files TLX250-CDx (Zircaix®) BLA for Kidney Cancer Imaging
MELBOURNE, Australia and INDIANAPOLIS, Dec. 30, 2024 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX; Nasdaq: TLX, Telix, the Company) […]
Lifeward Announces Postponement of its Extraordinary General Meeting of Shareholders
MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Dec. 27, 2024 (GLOBE NEWSWIRE) — Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), […]
Radius Recycling Announces First Quarter Fiscal 2025 Earnings Date and Webcast Details
PORTLAND, Ore., Dec. 27, 2024 (GLOBE NEWSWIRE) — Radius Recycling, Inc. (NASDAQ: RDUS) announced that the Company will report financial […]
Psyence Biomed Announces Closing of $2.0 Million Private Placement
NEW YORK, Dec. 27, 2024 (GLOBE NEWSWIRE) — Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence Biomed” or the “Company”) today announced […]
Vincerx Pharma Enters into a Binding Term Sheet for a Strategic Merger with Oqory, Inc.
PALO ALTO, Calif., Dec. 27, 2024 (GLOBE NEWSWIRE) — Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address […]
Nutriband Extends Chinese Patent to Macao for its AVERSA™ Abuse Deterrent Transdermal Technology
Nutriband’s abuse-deterrent platform technology is now patented in 46 countries and territories covering major global markets. Nutriband is targeting to […]
Vor Bio Announces $55.6 Million Private Placement
Intend to announce updated clinical data from Phase 1/2 VBP301 trial of VCAR33ALLOin the first half of 2025 and updated […]
AIX Completes Strategic Share Exchange with BGM to Drive Growth in AI Insurance and Healthcare
GUANGZHOU, China, Dec. 27, 2024 (GLOBE NEWSWIRE) — AIX Inc. (the “Company” or AIX) (NASDAQ: AIFU), a leading independent technology-driven […]
BTCS Announces the Sunset of StakeSeeker Platform to Focus on Ethereum Blockchain Infrastructure
Silver Spring, MD, Dec. 27, 2024 (GLOBE NEWSWIRE) — BTCS Inc. (Nasdaq: BTCS) (“BTCS” or the “Company”), a leader in […]
PainReform Provides Further Update on Phase 3 Clinical Trial of PRF-110
TEL AVIV, Israel, Dec. 27, 2024 (GLOBE NEWSWIRE) — PainReform Ltd. (Nasdaq: PRFX) (“PainReform” or the “Company“), a clinical-stage specialty […]
